BeiGene Market Cap

BeiGene has a market cap or net worth of 208.76 billion as of April 24, 2025. Its market cap has increased by 70.36% in one year.

Market Cap

208.76B

Enterprise Value

196.75B

Revenue

29.60B

Ranking

n/a

PE Ratio

n/a

Stock Price

152.20

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 6.70B to 208.76B, an increase of 3,017.26%. That is a compound annual growth rate of 45.19%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	208.76B	36.65%
Dec 31, 2024	152.77B	4.09%
Dec 29, 2023	146.76B	-17.60%
Dec 30, 2022	178.11B	-17.96%
Dec 31, 2021	217.12B	19.19%
Dec 31, 2020	182.15B	130.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hansoh Pharmaceutical Group Company	131.15B
JD Health International	113.19B
WuXi Biologics	82.98B
Innovent Biologics	77.88B
Akeso	74.45B
Alibaba Health Information Technology	73.50B
Sino Biopharmaceutical	65.67B
Sichuan Kelun-Biotech Biopharmaceutical	64.86B

Market Cap Rankings